Publications

Go back to Resources

Patient-Caregiver Discrepancy Score: Multisite Evaluation of a Novel Pediatric Outcome Measure

11/2025

Journal Article

Authors:
Shemesh, E.; Ng, V. L.; Dunphy, C.; Logan, S. ; Chessell, J.; Swami, N.; Lobritto, S. J.; Gupta, N. A.; Perito, E. R.; Hsu, E. K.; Pieratt, D.; Kwan, K.; DeGroote, C.; Srinivasan, S.; Anand, R.; Anderson, S. G.; Mueller, N.; Kleinman, L. C.; Mazariegos, G. V.

Journal:
J Pediatr

PMID:
41242693

URL:
https://www.ncbi.nlm.nih.gov/pubmed/41242693

DOI:
10.1016/j.jpeds.2025.114900

Keywords:
patient reported outcome measures PROMs Children Transplantation Liver

Abstract:
OBJECTIVE: To evaluate the relationship between patient outcomes and a discrepancy score, a new way to quantify caretaker vs child discrepancies on patient reported outcome measures (PROMs). STUDY DESIGN: Children between 8-18 years of age, at least one year from a primary liver transplantation, and their primary adult caretaker were recruited in a prospective, hypothesis-driven cohort study conducted in seven centers (USA, Canada) from the Starzl Network for Excellence in Pediatric Transplantation. A novel electronic application ("app") computed a "discrepancy score": the absolute cumulative value of each year's difference in scores between child and caretaker responses on a Health-Related Quality of Life (HRQoL) questionnaire. Liver and HRQoL outcomes were also evaluated. RESULTS: Of 200 enrolled, 160 patients / 140 dyads answered the questionnaire at least once; 101 patients / 85 dyads answered twice. Median age was 13 years old, and 60.6% were females. HRQoL was not associated with liver outcomes but was associated with discrepancy scores in both the first and second administration: Pearson correlation -0.469 (95% CI: -0.588, -0.328, p<0.01), and -0.347 (95% CI: -0.520, -0.143, p<0.01), respectively. CONCLUSIONS: Quantifying differences between child and caretaker PROMs in a "discrepancy score" is a novel way to interpret PROM results. Decreasing discrepancies could be a reasonable clinical target.

Go back to Resources